Key facts
- This page summarizes Daniel M. Schmitt's Form 4 filing for ACTUATE THERAPEUTICS, INC. (ACTU).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Oct 2026, 09:35.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Purchase
Additional SEC filing notes
Footnote F1
Represents shares of common stock purchased on October 28, 2026 in connection with Issuers public offering.
Footnote F2
Represents detachable warrants acquired on October 28, 2026 in connection with Issuers public offering. For every two shares of common stock acquired in connection with the public offering, one detachable warrant was issued for no additional consideration. The warrant is immediately exercisable and expires 5 years from this issuance date.
Footnote F3
Represents shares held by The Schmitt Family Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee (the "Schmitt Family Trust").
Footnote F4
Represents shares held by The Andrew Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
Footnote F5
Represents shares held by The Anna Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.
Footnote F6
Represents shares held by The Edward Schmitt Irrevocable Trust, dated December 31, 2019, of which the reporting person is trustee.